The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Aristea S. Galanopoulou sits on this spectrum.
This scientist: 194 publications — 60th percentile
60% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 887 publications or more.
The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Aristea S. Galanopoulou sits on this spectrum.
This scientist: 48 D-Index — 37th percentile
37% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 163 D-Index or more.
Aristea S. Galanopoulou is affiliated with the Albert Einstein College of Medicine in the United States. Their research primarily focuses on epilepsy and neuroscience, with a significant body of work in medicine and neurology. Their contributions span several interconnected fields, including psychiatry and mental health, cellular and molecular neuroscience, molecular biology, and cognitive neuroscience.
Their research interests cover a variety of topics, particularly in epilepsy research and treatment, neuroscience and neuropharmacology, pharmacological effects and toxicity studies, traumatic brain injury and neurovascular disturbances, EEG and brain-computer interfaces, long-term effects of COVID-19, and functional brain connectivity studies.
Key publications by Aristea S. Galanopoulou include:
They frequently collaborate with other researchers, including Solomon L. Moshé, Terence J. O'Brien, Dong Zhou, Stéphane Auvin, and Pablo M. Casillas-Espinosa.
The scientist has contributed extensively to several academic journals, notably publishing multiple papers in Epilepsia Open and Epilepsia, alongside publications in the Journal of Neurotrauma, Movement Disorders Clinical Practice, and Pharmacological Reviews.
The focus of their published research reflects a blend of clinical and preclinical approaches to understanding neurological disorders with an emphasis on epileptogenesis, seizure management, and neurophysiological diagnostics. They have also explored the impact of acute illness, including COVID-19, on neurological conditions.
Aristea S. Galanopoulou;Paul S. Buckmaster;Kevin J. Staley;Solomon L. Moshé
Aristea S Galanopoulou;Aviva Bojko;Fred Lado;Solomon L Moshé
Jana Velíšková;Libor Velíšek;Aristea S. Galanopoulou;Ellen F. Sperber
Aristea S. Galanopoulou
Aristea S. Galanopoulou;Jan A. Gorter;Carlos Cepeda
Aristea S Galanopoulou
Morris H. Scantlebury;Aristea S. Galanopoulou;Lenka Chudomelova;Emmanuel Raffo
Amy R. Brooks-Kayal;Kevin G. Bath;Anne T. Berg;Aristea S. Galanopoulou
Unknown
Emmanuel Raffo;Antonietta Coppola;Antonietta Coppola;Tomonori Ono;Stephen W. Briggs
Aristea S. Galanopoulou
Aristea S. Galanopoulou;Victor Ferastraoaru;Daniel J. Correa;Koshi Cherian
Michele Simonato;Amy R Brooks-Kayal;Jerome Engel;Aristea S Galanopoulou
Melissa L. Barker-Haliski;Wolfgang Löscher;H. Steve White;Aristea S. Galanopoulou
Stephen W. Briggs;Aristea S. Galanopoulou
Asla Pitkänen;Astrid Nehlig;Amy R. Brooks-Kayal;F. Edward Dudek
Aristea S. Galanopoulou
Carlos A. Pardo;Rima Nabbout;Aristea S. Galanopoulou
Aristea S Galanopoulou;Elizabeth Medina Alm;Elizabeth Medina Alm;Jana Velı́šková
T Ravizza;A.S Galanopoulou;J Velı́šková;S.L Moshé
Jana Velís̆ková;Olga I. Claudio;Aristea S. Galanopoulou;Fred A. Lado
If you think any of the details on this page are incorrect, let us know.
Nanjing University of Posts and Telecommunications
Agricultural Research Service
University of California, Berkeley
Harvard University
University of Wisconsin–Madison
University of Bordeaux
Colorado State University
University of Clermont Auvergne
Northwestern University
Scripps Research Institute
Shaanxi Normal University
University of Southern California
University of Rochester
University of California, Los Angeles
Georgia Institute of Technology
University of Kentucky
